Monocytes, but not endothelial cells, downregulate the anticoagulant activity of activated protein C

British Journal of Haematology

Volumn 112, Issue 2, 2001, Pages 519-526

  Colucci, Mario ^a,c   Stramaglia, Anna M ^a   Mascolo, Elisa ^a   Napoleone, Emanuela ^b   Lorenzet, Roberto ^b   Semeraro, Nicola ^a  

^a UNIVERSITY OF BARI   (Italy)

^b Consorzio Mario Negri Sud ^*  (Italy)

^c POLICLINICO   (Italy)

Author keywords

APC resistance; Coagulation; Endothelial cells; Mononuclear cells

Indexed keywords

ACTIVATED PROTEIN C; ANTICOAGULANT AGENT; BLOOD CLOTTING FACTOR 5A; BLOOD CLOTTING FACTOR 8A; LIPOPOLYSACCHARIDE; THROMBOPLASTIN;

ANTICOAGULATION; ARTICLE; BLOOD CLOTTING TIME; CELL STRAIN U937; CONTROLLED STUDY; DOWN REGULATION; ENDOTHELIUM CELL; FIBRIN DEPOSITION; HUMAN; HUMAN CELL; MONOCYTE; PRIORITY JOURNAL; THROMBIN TIME; UMBILICAL VEIN;

ANTICOAGULANTS; BLEEDING TIME; CELLS, CULTURED; ENDOTHELIUM, VASCULAR; FACTOR VA; HUMANS; LEUKOCYTES, MONONUCLEAR; LIPOPOLYSACCHARIDES; PROTEIN C; THROMBIN; THROMBOPLASTIN; U937 CELLS;

EID: 0035120770     PISSN: 00071048     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2141.2001.02563.x     Document Type: Article

References (35)

1. Xa receptor EPR-1
2. High prevalence of a mutation in the factor V gene within the UK population: Relationship to activated protein C resistance and familial thrombosis
3. Molecular risk factors for thrombosis
4. Mutation in blood coagulation factor V associated with resistance to activated protein C
5. Prothrombin contributes to the assembly of the factor Va-factor Xa complex at phosphatidylserine-containing phospholipid membranes
6. A rapid method of total lipid extraction and purification
7. Anticoagulant properties of the vascular endothelium
8. Isolation of lymphocytes, granulocytes and macrophages
9. Cell biology of tissue factor, the principal initiator of blood coagulation
10. Platelet-derived factor Va/Va Leiden cofactor activities are sustained on the surface of activated platelets despite the presence of activated protein C
11. Endothelial cells in physiology and in the pathophysiology of vascular disorders
12. Cultured human endothelial cells generate tissue factor in response to endotoxin
13. Familial thrombophilia due to a previously unrecognized mechanism characterized by poor anticoagulant response to activated protein C: Prediction of a cofactor to activated protein C
14. Role of leukocytes in the activation of blood coagulation
15. Regulation of blood coagulation
16. The unstable atherosclerotic plaque: Clinical significance and therapeutic intervention
17. Culture of vascular endothelium
18. Variability of thrombosis among homozygous siblings with resistance to activated protein C due to an Arg→Gln mutation in the gene for factor V
19. Characterization of monocyte-associated factor V
20. Cell-cell interaction and tissue factor expression
21. Cofactor proteins in the assembly and expression of blood clotting enzyme complexes
22. Tissue factor expression by monocytes: Regulation and pathophysiological roles
23. Arachidonic acid metabolism by human monocytes
24. Multicenter evaluation of a kit for activated protein C resistance on various coagulation instruments using plasmas from healthy individuals
25. Structural biology of tissue factor, the initiator of thrombogenesis in vivo
26. Tissue factor in health and disease
27. Direct induction of tissue factor synthesis by endotoxin in human macrophages from diverse anatomical sites
28. Contribution of different phospholipid classes to the prothrombin converting capacity of sonicated lipid vesicles
29. Phosphatidylethanolamine incorporation into vescicles selectively enhances FVa inactivation by activated protein C
30. The effect of membrane composition on the hemostatic balance
31. Activated protein C resistance: Effect of platelets, platelet-derived microparticles and atherogenic lipoproteins
32. Functional prothrombinase complex assembly on isolated monocytes and lmphocytes
33. Phospholipid bound tissue factor modulates both thrombin generation and APC-mediated factor Va inactivation
34. Identification of the same factor V gene mutation in 47 out of 50 thrombosisprone families with inherited resistance to activated protein C
35. Lipid-protein interactions in blood coagulation